Cargando…
Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study
Introduction: In India, the costs of cancer drugs are exorbitant and cause significant financial toxicity to the affected patient and their family members. Considering this, Jan Aushadhi pharmacy stores were established across the country by the government of India with the objective of providing ch...
Autores principales: | George, Thomas, Baliga, Manjeshwar S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642137/ https://www.ncbi.nlm.nih.gov/pubmed/34877208 http://dx.doi.org/10.7759/cureus.19231 |
Ejemplares similares
-
A Cost Analysis of the Jan Aushadhi Scheme in India
por: Mukherjee, Kanchan
Publicado: (2017) -
Why the Jan Aushadhi Scheme Has Lost Its Steam in India?
por: Thawani, Vijay, et al.
Publicado: (2017) -
A cost analysis and availability scenario of drugs and oral care products prescribed for common oral conditions with reference to the current Indian market prices, Jan Aushadhi, and the state medical commissions
por: Gauthaman, Jeevitha
Publicado: (2022) -
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014) -
Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan
por: Hsu, Chih-Wei, et al.
Publicado: (2020)